Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance(TM) (ANP1) for Hearing Loss
Stock Information for Lineage Cell Therapeutics, Inc.
Loading
Please wait while we load your information from QuoteMedia.
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.